Katarina Sjögreen Gleisner
31 – 40 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Bone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases
- Contribution to journal › Article
-
Mark
Re : Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma
- Contribution to journal › Letter
- 2018
-
Mark
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
- Contribution to journal › Article
-
Mark
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
- Contribution to journal › Article
-
Mark
A method for tumor dosimetry based on hybrid planar-SPECT/CT images and semiautomatic segmentation
- Contribution to journal › Article
-
Mark
Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals
- Contribution to journal › Article
-
Mark
From fixed activities to personalized treatments in radionuclide therapy : lost in translation?
- Contribution to journal › Article
-
Mark
3-D Image-Based Dosimetry in Radionuclide Therapy
- Contribution to journal › Scientific review
- 2017
-
Mark
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
- Contribution to journal › Article
-
Mark
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
- Contribution to journal › Article
